FDA OKs first cannabinoid, gives green light to GW Pharma’s Epidiolex for rare seizures
GW Pharma $GWPH finished its layup at the FDA today with Epidiolex, grabbing its first ever marketing OK for one of its cannabinoid drugs and …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
